These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study. Gottlieb AB; Kircik L; Eisen D; Jackson JM; Boh EE; Strober BE; Frankel E; Xia HA; Stevens SR J Dermatolog Treat; 2006; 17(6):343-52. PubMed ID: 17853307 [TBL] [Abstract][Full Text] [Related]
24. Puerto Rico psoriasis study group: efficacy and safety of etanercept. González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Kaltwasser JP; Nash P; Gladman D; Rosen CF; Behrens F; Jones P; Wollenhaupt J; Falk FG; Mease P; Arthritis Rheum; 2004 Jun; 50(6):1939-50. PubMed ID: 15188371 [TBL] [Abstract][Full Text] [Related]
26. [Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases]. Krüger K Z Rheumatol; 1995; 54(2):89-95. PubMed ID: 7793161 [TBL] [Abstract][Full Text] [Related]
27. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy. Eşrefoğlu M; Gül M; Seyhan M Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475 [TBL] [Abstract][Full Text] [Related]
28. [Chloroquine in the treatment of psoriatic arthritis]. Jajić Z; Jajić I; Grazio S Reumatizam; 1995; 42(2):7-9. PubMed ID: 8693205 [TBL] [Abstract][Full Text] [Related]
29. Multidisciplinary focus on cyclosporin A. Salvarani C; Boiardi L; Macchioni P; Pipitone N; Catanoso M; Pigatto P J Rheumatol Suppl; 2009 Aug; 83():52-5. PubMed ID: 19661542 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis. Wagner SA; Peter RU; Adam O; Ruzicka T Dermatology; 1993; 186(1):62-7. PubMed ID: 8435521 [TBL] [Abstract][Full Text] [Related]
31. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Stanway A; Rademaker M; Newman P Australas J Dermatol; 2004 May; 45(2):119-22. PubMed ID: 15068460 [TBL] [Abstract][Full Text] [Related]
32. [The efficacy of diclonate P in psoriatic arthritis]. Burdeĭnyĭ AP Ter Arkh; 1994; 66(5):75-7. PubMed ID: 7940348 [TBL] [Abstract][Full Text] [Related]
33. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile. Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346 [TBL] [Abstract][Full Text] [Related]
34. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Antoni C; Dechant C; Hanns-Martin Lorenz PD; Wendler J; Ogilvie A; Lueftl M; Kalden-Nemeth D; Kalden JR; Manger B Arthritis Rheum; 2002 Oct; 47(5):506-12. PubMed ID: 12382299 [TBL] [Abstract][Full Text] [Related]
35. Cyclosporin A treatment for idiopathic membranous nephropathy. Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859 [TBL] [Abstract][Full Text] [Related]